Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Susanne Koletnik"'
Autor:
Dennis Doleschel, Sabine Hoff, Susanne Koletnik, Anne Rix, Dieter Zopf, Fabian Kiessling, Wiltrud Lederle
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-14 (2021)
Abstract Background Patients with advanced colorectal cancer (CRC) have a poor prognosis. Combinations of immunotherapies and anti-angiogenic agents are currently being evaluated in clinical trials. In this study, the multikinase inhibitor regorafeni
Externí odkaz:
https://doaj.org/article/f1af03bb86884972b957d7874ccb7a22
Autor:
Flurin Mueller-Diesing, Wiltrud Lederle, Anne Rix, Susanne Koletnik, Dennis Doleschel, Maximilian Snelting, Felix Gremse, Fabian Kiessling
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 8, p 7060 (2023)
Acetylsalicylic acid (ASA) is a well-established drug for heart attack and stroke prophylaxis. Furthermore, numerous studies have reported an anti-carcinogenic effect, but its exact mechanism is still unknown. Here, we applied VEGFR-2-targeted molecu
Externí odkaz:
https://doaj.org/article/5a71ff0a21ec43a49a8227995aec30c4
Autor:
Sara Zafarnia, Jessica Bzyl-Ibach, Igor Spivak, Yongping Li, Susanne Koletnik, Dennis Doleschel, Anne Rix, Sibylle Pochon, Isabelle Tardy, Seena Koyadan, Marc van Zandvoort, Moritz Palmowski, Fabian Kiessling, Wiltrud Lederle
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 19, Iss 11, Pp 896-907 (2017)
Vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR)-targeted therapies predominantly affect nascent, immature tumor vessels. Since platelet-derived growth factor receptor (PDGFR) blockade inhibits vessel maturation and thus increases the
Externí odkaz:
https://doaj.org/article/0bfad39e91c6449da9f7b6358df61396
Autor:
Susanne Koletnik, Dennis Doleschel, Fabian Kiessling, Anne Rix, Wiltrud Lederle, Dieter Zopf, Sabine Hoff
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Journal of experimental & clinical cancer research 40(1), 288 (2021). doi:10.1186/s13046-021-02043-0
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-14 (2021)
Journal of experimental & clinical cancer research 40(1), 288 (2021). doi:10.1186/s13046-021-02043-0
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-14 (2021)
Journal of experimental & clinical cancer research 40(1), 288 (2021). doi:10.1186/s13046-021-02043-0
Published by Springer, Berlin ; Heidelberg
Published by Springer, Berlin ; Heidelberg
Autor:
Anne Rix, Volkmar Schulz, Susanne Koletnik, Teresa Nolte, Wiltrud Lederle, F. Baskaya, Fabian Kiessling
Publikováno v:
102. Deutscher Röntgenkongress der Deutschen Röntgengesellschaft e. V..
Autor:
Fabian Kiessling, E. Fiegle, Susanne Koletnik, Dennis Doleschel, Anne Rix, Erawan Borkham-Kamphorst, Ralf Weiskirchen, Wiltrud Lederle
Publikováno v:
Neoplasia 21(9), 932-944 (2019). doi:10.1016/j.neo.2019.07.006
Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 9, Pp 932-944 (2019)
Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 9, Pp 932-944 (2019)
Immune checkpoint inhibitors have shown clinical benefit in several cancer entities including metastatic microsatellite instable colorectal carcinomas. However, for the majority of metastatic colorectal carcinomas the potential and limitations of imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aa9820dfe2a05de7562c0345dc26993